Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
FEMS Microbiol Lett ; 3702023 01 17.
Article in English | MEDLINE | ID: mdl-37491691

ABSTRACT

In response to the challenges presented by the COVID-19 pandemic, this paper proposes an exam system for STEM students that effectively test higher-order thinking skills, such as the ability to apply, create, evaluate, and analyse. Higher education institutions (HEIs) must incorporate all three strands of democratic STEM pedagogy, namely student voice, shared and transformational authority, and STEM criticality, according to empathy interviews with educators. It is imperative that these strands are reflected in the assessments of students within HEIs. During the pandemic, it became evident that the lack of a suitable proctored online examination system impeded the accurate and fair evaluation of students. This circumstance was in stark contrast to the offline mode of examination, which permitted monitoring and control. Notably, many students struggled to answer questions requiring higher-order thinking, with responses frequently identical in unproctored online examinations or settings with insufficient proctoring mechanisms, especially in contexts with limited resources. Consequently, there is an urgent need to redesign the online proctored test system in accordance with STEM criticality and student voice. To address this need, this paper proposes the creation of OPERHOT, a proctored online exam system integrated with random questions requiring higher-order thinking. This system employs a timed assessment methodology and requires students to keep their cameras on throughout the examination. By implementing OPERHOT, a proper and secure online evaluation of students can be made possible. In addition, this system will strengthen the online education and assessment systems in HEIs, thereby promoting integrity and enhancing the learning experience. In addition, the adoption of OPERHOT will also improve the assessment process and contribute to the enhancement of online education and assessment in HEIs as a whole. This reimagined system will catalyse the development of a robust and inclusive learning environment that encourages students' voices and equips educators to foster the growth of critical thinking and problem-solving skills. This perspective aims to address the pressing need for an updated and effective proctored assessment system in the online educational landscape while promoting STEM critical thinking and student voice. The OPERHOT platform is at the ideation stage, and once developed, it may be tested in a few HEIs. Based on the feedback from educators and other stakeholders, it can be further modified to make it more inclusive and accessible and can be offered to other HEIs for wider piloting.


Subject(s)
COVID-19 , Pandemics , Humans , COVID-19/diagnosis , Thinking , Learning , Educational Measurement/methods
2.
J Immunother Cancer ; 11(6)2023 06.
Article in English | MEDLINE | ID: mdl-37321663

ABSTRACT

BACKGROUND: Locally advanced/recurrent head and neck squamous cell carcinoma (HNSCC) is associated with significant morbidity and mortality. To target upregulated ErbB dimer expression in this cancer, we developed an autologous CD28-based chimeric antigen receptor T-cell (CAR-T) approach named T4 immunotherapy. Patient-derived T-cells are engineered by retroviral transduction to coexpress a panErbB-specific CAR called T1E28ζ and an IL-4-responsive chimeric cytokine receptor, 4αß, which allows IL-4-mediated enrichment of transduced cells during manufacture. These cells elicit preclinical antitumor activity against HNSCC and other carcinomas. In this trial, we used intratumoral delivery to mitigate significant clinical risk of on-target off-tumor toxicity owing to low-level ErbB expression in healthy tissues. METHODS: We undertook a phase 1 dose-escalation 3+3 trial of intratumoral T4 immunotherapy in HNSCC (NCT01818323). CAR T-cell batches were manufactured from 40 to 130 mL of whole blood using a 2-week semiclosed process. A single CAR T-cell treatment, formulated as a fresh product in 1-4 mL of medium, was injected into one or more target lesions. Dose of CAR T-cells was escalated in 5 cohorts from 1×107-1×109 T4+ T-cells, administered without prior lymphodepletion. RESULTS: Despite baseline lymphopenia in most enrolled subjects, the target cell dose was successfully manufactured in all cases, yielding up to 7.5 billion T-cells (67.5±11.8% transduced), without any batch failures. Treatment-related adverse events were all grade 2 or less, with no dose-limiting toxicities (Common Terminology Criteria for Adverse Events V.4.0). Frequent treatment-related adverse events were tumor swelling, pain, pyrexias, chills, and fatigue. There was no evidence of leakage of T4+ T-cells into the circulation following intratumoral delivery, and injection of radiolabeled cells demonstrated intratumoral persistence. Despite rapid progression at trial entry, stabilization of disease (Response Evaluation Criteria in Solid Tumors V.1.1) was observed in 9 of 15 subjects (60%) at 6 weeks post-CAR T-cell administration. Subsequent treatment with pembrolizumab and T-VEC oncolytic virus achieved a rapid complete clinical response in one subject, which was durable for over 3 years. Median overall survival was greater than for historical controls. Disease stabilization was associated with the administration of an immunophenotypically fitter, less exhausted, T4 CAR T-cell product. CONCLUSIONS: These data demonstrate the safe intratumoral administration of T4 immunotherapy in advanced HNSCC.


Subject(s)
Head and Neck Neoplasms , Receptors, Chimeric Antigen , Humans , Squamous Cell Carcinoma of Head and Neck/therapy , Interleukin-4 , Neoplasm Recurrence, Local , Immunotherapy , Head and Neck Neoplasms/drug therapy
3.
Article in English | MEDLINE | ID: mdl-36636617

ABSTRACT

Biofilm refers to microbes that associate with each other or to a surface via self-synthesized exopolysaccharides and other surface-related structures. The presence of biofilms consisting of pathogenic microbes in the food and clinical environment can pose a threat to human health as microbes in biofilms are highly robust and are difficult to remove. Understanding the process of biofilm formation is crucial for the development of novel strategies to control or harness biofilm. The complex network of proteins, small RNA, and diverse molecules regulate biofilm formation at different steps in biofilm development, including triggering the switch from planktonic to sessile cells, maturation of biofilms, and eventual dispersion of microbes from the biofilms. Small non-coding RNAs are relatively small RNAs that are not translated into proteins and play diverse roles in metabolism, physiology, pathogenesis, and biofilm formation. In this review, we primarily focused on non-coding regulatory RNA that regulates biofilm formation in clinically relevant pathogens or threatens human health. Even though many ncRNA have recently been identified in Archaea, much characterization work remains. The mechanisms and regulatory processes controlled by ncRNA in prokaryotes are covered in this review.

4.
Onderstepoort J Vet Res ; 89(1): e1-e12, 2022 Oct 10.
Article in English | MEDLINE | ID: mdl-36331207

ABSTRACT

Antimicrobial resistance (AMR) is a global public health threat for both human and veterinary medicine. Increasing evidence suggests that animals are important sources of AMR to humans; however, most of these studies focus on production animals. In order to determine the pattern of AMR in pets, mainly in dogs in Africa, a meta-analysis was performed with AMR studies conducted in African countries and published between January 2000 and January 2021 in four databases: Medline (PubMed), Scopus, Cab abstract and Google Scholar. Seven bacterial strains, namely Staphylococcus aureus, Escherichia coli, Salmonella spp., Pseudomonas aeruginosa, Streptococcus pyogenes, coagulase-negative Staphylococcus (SNC) and Staphylococcus pseudintermedius were included in this study. A total of 18 out of 234 indexed articles met the study criteria. The results revealed that multiple bacteria were resistant to various commonly used antibiotics including enrofloxacin, ciprofloxacin, gentamicin, amoxicillin, clavulanic acid, cotrimoxazole, streptomycin, tetracycline and chloramphenicol. Concerning multidrug resistance, E. coli strains came first with the highest prevalence of 98%, followed by P. aeroginosa (92%) and Salmonella spp. (53%). In contrast, the overall prevalence of multidrug resistance was low for S. aureus (18%) and S. pseudintermedius (25%). It is therefore urgent to find, as soon as possible, alternatives to replace these antibiotics, which have become ineffective in controlling these bacteria in dogs in Africa. Moreover, further metagenomic studies are needed to describe the full resistome and mobilome in dogs regardless of the bacteria.


Subject(s)
Anti-Bacterial Agents , Drug Resistance, Bacterial , Dogs , Animals , Humans , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Escherichia coli , Staphylococcus aureus , Prevalence , Bacteria
5.
Access Microbiol ; 4(1): 000318, 2022.
Article in English | MEDLINE | ID: mdl-35252755

ABSTRACT

Sewage-based surveillance for COVID-19 has been described in multiple countries and multiple settings. However, nearly all are based on testing sewage treatment plant inflows and outflows using structured sewage networks and treatment systems. Many resource-limited countries worldwide have open canals, lakes and other such waste-contaminated water bodies that act as a means of sewage effluent discharge. These could serve as hyperlocal testing points for detecting COVID-19 incidence using the effluents from nearby communities. However, a sensitive, robust and economical method of SARS-CoV-2 RNA detection from open waste contaminated water bodies in resource-constrained regions is currently lacking. A protocol employed in Bangalore, India, where SARS-CoV-2 RNA levels were evaluated using two open canal systems during the first and second waves in the present study. SARS-CoV-2 RNA was measured using two strategies: a modified TrueNATTM microchip-based rapid method and traditional real-time reverse transcription-PCR (rRT-PCR), which were compared for analytical sensitivity, cost and relative ease of use. SARS-CoV-2 RNA levels were detected at lower levels during the earlier half compared to the later half of the first wave in 2020. The opposite trend was seen in the second wave in 2021. Interestingly, the change in RNA levels corresponded with the community burden of COVID-19 at both sites. The modified TrueNATTM method yielded concordant results to traditional rRT-PCR in sensitivity and specificity and cost. It provides a simple, cost-effective method for detecting and estimating SARS-CoV-2 viral RNA from open-water sewage canals contaminated with human excreta and industrial waste that can be adopted in regions or countries that lack structured sewage systems.

6.
Curr Opin Pharmacol ; 60: 158-167, 2021 10.
Article in English | MEDLINE | ID: mdl-34425392

ABSTRACT

Ebola virus disease targets and destroys immune cells, including macrophages and dendritic cells, leading to impairment of host response. After infection, a combination of strategies including alteration and evasion of immune response culminating in a strong inflammatory response can lead to multi-organ failure and death in most infected patients. This review discusses immune response dynamics, mainly focusing on how Ebola manipulates innate and adaptive immune responses and strategizes to thwart host immune responses. We also discuss the challenges and prospects of developing therapeutics and vaccines against Ebola.


Subject(s)
Ebolavirus , Hemorrhagic Fever, Ebola , Humans , Immunity, Innate , Macrophages
7.
Arch Pharm (Weinheim) ; 354(8): e2100034, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33913195

ABSTRACT

Among peptide-based drugs, naturally occurring bicyclic compounds have been established as molecules with unique therapeutic potential. The diverse pharmacological activities associated with bicyclic peptides from marine tunicates, sponges, and bacteria render them suitable to be employed as effective surrogate between complex and small therapeutic moieties. Bicyclic peptides possess greater conformational rigidity and higher metabolic stability as compared with linear and monocyclic peptides. The antibody-like affinity and specificity of bicyclic peptides enable their binding to the challenging drug targets. Bridged macrobicyclic peptides from natural marine resources represent an underexplored class of molecules that provides promising platforms for drug development owing to their biocompatibility, similarity, and chemical diversity to proteins. The present review explores major marine-derived bicyclic peptides including disulfide-bridged, histidinotyrosine-bridged, or histidinoalanine-bridged macrobicyclic peptides along with their structural characteristics, synthesis, structure-activity relationship, and bioproperties.The comparison of these macrobicyclic congeners with linear/monocyclic peptides along with their therapeutic potential are also briefly discussed.


Subject(s)
Aquatic Organisms/metabolism , Biological Products/pharmacology , Peptides, Cyclic/pharmacology , Animals , Biological Products/chemical synthesis , Biological Products/chemistry , Drug Development , Humans , Peptides, Cyclic/chemical synthesis , Peptides, Cyclic/chemistry , Structure-Activity Relationship
8.
Cytotherapy ; 20(6): 830-838, 2018 06.
Article in English | MEDLINE | ID: mdl-29753677

ABSTRACT

BACKGROUND: Adenovirus (ADV) reactivation can cause significant morbidity and mortality in children after allogeneic stem cell transplantation. Antiviral drugs can control viremia, but viral clearance requires recovery of cell-mediated immunity. METHOD: This study was an open-label phase 1/2 study to investigate the feasibility of generating donor-derived ADV-specific T cells (Cytovir ADV, Cell Medica) and to assess the safety of pre-emptive administration of ADV-specific T cells in high-risk pediatric patients after allogeneic hematopoietic stem cell transplantation (HSCT) to treat adenoviremia. Primary safety endpoints included graft-versus-host disease (GvHD), and secondary endpoints determined antiviral responses and use of antiviral drugs. RESULTS: Between January 2013 and May 2016, 92 donors were enrolled for the production of ADV T cells at three centers in the United Kingdom (UK), and 83 products were generated from 72 mobilized peripheral blood harvests and 20 steady-state whole blood donations. Eight children received Cytovir ADV T cells after standard therapy and all resolved ADV viremia between 15 and 127 days later. ADV-specific T cells were detectable using enzyme-linked immunospot assay (ELISpot) in the peripheral blood of all patients analyzed. Serious adverse events included Grade II GvHD, Astrovirus encephalitis and pancreatitis. CONCLUSION: The study demonstrates the safety and feasibility of pre-emptively manufacturing peptide pulsed ADV-specific cells for high-risk pediatric patients after transplantation and provides early evidence of clinical efficacy.


Subject(s)
Adenoviridae Infections/prevention & control , Adenoviridae/immunology , Graft vs Host Disease/prevention & control , Hematologic Neoplasms , Hematopoietic Stem Cell Transplantation , Immunotherapy, Adoptive/methods , T-Lymphocytes/transplantation , Adenoviridae Infections/complications , Adenoviridae Infections/immunology , Adolescent , Child , Child, Preschool , Female , Graft vs Host Disease/virology , Hematologic Neoplasms/complications , Hematologic Neoplasms/immunology , Hematologic Neoplasms/therapy , Hematologic Neoplasms/virology , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cell Transplantation/methods , Humans , Immunity, Cellular , Infant , Male , Risk Factors , T-Lymphocytes/immunology , Transplantation Immunology , Transplantation, Homologous/adverse effects , Treatment Outcome , Virus Activation/immunology
9.
PLoS One ; 11(6): e0157532, 2016.
Article in English | MEDLINE | ID: mdl-27362507

ABSTRACT

The quorum sensing molecule Autoinducer-2 (AI-2) is generated as a byproduct of activated methyl cycle by the action of LuxS in Escherichia coli. AI-2 is synthesized, released and later internalized in a cell-density dependent manner. Here, by mutational analysis of the genes, uvrY and csrA, we describe a regulatory circuit of accumulation and uptake of AI-2. We constructed a single-copy chromosomal luxS-lacZ fusion in a luxS + merodiploid strain and evaluated its relative expression in uvrY and csrA mutants. At the entry of stationary phase, the expression of the fusion and AI-2 accumulation was positively regulated by uvrY and negatively regulated by csrA respectively. A deletion of csrA altered message stability of the luxS transcript and CsrA protein exhibited weak binding to 5' luxS regulatory region. DNA protein interaction and chromatin immunoprecipitation analysis confirmed direct interaction of UvrY with the luxS promoter. Additionally, reduced expression of the fusion in hfq deletion mutant suggested involvement of small RNA interactions in luxS regulation. In contrast, the expression of lsrA operon involved in AI-2 uptake, is negatively regulated by uvrY and positively by csrA in a cell-density dependent manner. The dual role of csrA in AI-2 synthesis and uptake suggested a regulatory crosstalk of cell signaling with carbon regulation in Escherichia coli. We found that the cAMP-CRP mediated catabolite repression of luxS expression was uvrY dependent. This study suggests that luxS expression is complex and regulated at the level of transcription and translation. The multifactorial regulation supports the notion that cell-cell communication requires interaction and integration of multiple metabolic signals.


Subject(s)
Cell Communication/physiology , Escherichia coli/metabolism , Homoserine/analogs & derivatives , Lactones/metabolism , Carbon/metabolism , Escherichia coli/genetics , Gene Expression Regulation, Bacterial , Homoserine/metabolism , Promoter Regions, Genetic
10.
Cytotherapy ; 18(9): 1209-18, 2016 09.
Article in English | MEDLINE | ID: mdl-27424147

ABSTRACT

BACKGROUND AIMS: In pediatric patients, adenovirus (ADV) reactivation after allogeneic hematopoietic stem cell transplantation (allo HSCT) is a major cause of morbidity and mortality. For patients who do not respond to antiviral drug therapy, a new treatment approach using ADV-specific T cells can present a promising alternative. Here we describe the clinical scale Good Manufacturing Practice (GMP)-compliant manufacture and characterization of 40 ADV-specific T-cell products, Cytovir ADV, which are currently being tested in a multi-center phase I/IIa clinical trial. This process requires minimal intervention, is high yield, and results in a pure T-cell product that is functional. METHODS: Mononuclear cells (2 × 10(7)) were cultured in a closed system in the presence of GMP-grade ADV peptide pool and cytokines for 10 days. On day 10, the T-cell product was harvested, washed in a closed system, counted and assessed for purity and potency. Additional characterization was carried out where cell numbers allowed. RESULTS: Thirty-eight of 40 products (95%) met all release criteria. Median purity of the cell product was 88.3% CD3+ cells with a median yield of 2.9 × 10(7) CD3+ cells. Potency analyses showed a median ADV-specific interferon (IFN)γ response of 5.9% of CD3+ and 2345 IFNγ spot-forming cells/million. CD4 and CD8 T cells were capable of proliferating in response to ADV (63.3 and 56.3%, respectively). These virus-specific T cells (VST) were heterogenous, containing both effector memory and central memory T cells. In an exemplar patient with ADV viremia treated in the open ASPIRE trial, ADV-specific T-cell response was detected by IFNγ enzyme-linked immunospot from 13 days post-infusion. ADV DNA levels declined following cellular therapy and were below level of detection from day 64 post-infusion onward. CONCLUSIONS: The clinical-scale GMP-compliant One Touch manufacturing system is feasible and yields functional ADV-specific T cells at clinically relevant doses.


Subject(s)
Adenoviridae , Cell Culture Techniques/methods , Hematopoietic Stem Cell Transplantation/adverse effects , T-Lymphocytes/cytology , Adenoviridae/pathogenicity , Adenoviridae/physiology , Adenoviridae Infections/therapy , Cell Culture Techniques/standards , Humans , Immunophenotyping , Immunotherapy/methods , T-Lymphocytes/virology
11.
Avian Dis ; 59(1): 52-6, 2015 Mar.
Article in English | MEDLINE | ID: mdl-26292534

ABSTRACT

Salmonella enterica serovar Gallinarum causes fowl typhoid, recognized worldwide as an economically important disease. The current vaccine, 9R, lacks a complete O antigen, which is a Salmonella virulence factor, and, in addition, has a number of other less well characterized chromosomal mutations. For optimal efficacy, 9R is administered by injection. In an effort to develop a vaccine suitable for oral administration, we constructed Salmonella Gallinarum strains with a reversible O-antigen phenotype. In this scenario, the vaccine strain produces full-length O antigen at the time it is administered to birds. After the vaccine has had time to colonize internal lymphoid tissues, the O-antigen is gradually lost, resulting in an attenuated strain. We found that strains carrying single mutations conferring this phenotype, Apmi and arabinose-regulated rfc, retained virulence. However, a mutant strain carrying both of these mutations was completely attenuated and immunogenic in chickens. This work demonstrates a novel approach for developing live Salmonella vaccines for poultry.


Subject(s)
Chickens , O Antigens/immunology , Poultry Diseases/prevention & control , Salmonella Infections, Animal/prevention & control , Typhoid-Paratyphoid Vaccines/immunology , Administration, Oral , Animals , Mutation , Poultry Diseases/microbiology , Salmonella/classification , Salmonella/genetics , Salmonella/pathogenicity , Salmonella Infections, Animal/immunology , Typhoid-Paratyphoid Vaccines/administration & dosage , Virulence
12.
Clin Vaccine Immunol ; 21(9): 1267-76, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24990908

ABSTRACT

Salmonella enterica serovar Gallinarum is the etiological agent of fowl typhoid, which constitutes a considerable economic problem for poultry growers in developing countries. The vaccination of chickens seems to be the most effective strategy to control the disease in those areas. We constructed S. Gallinarum strains with a deletion of the global regulatory gene fur and evaluated their virulence and protective efficacy in Rhode Island Red chicks and Brown Leghorn layers. The fur deletion mutant was avirulent and, when delivered orally to chicks, elicited excellent protection against lethal S. Gallinarum challenge. It was not as effective when given orally to older birds, although it was highly immunogenic when delivered by intramuscular injection. We also examined the effect of a pmi mutant and a combination of fur deletions with mutations in the pmi and rfaH genes, which affect O-antigen synthesis, and ansB, whose product inhibits host T-cell responses. The S. Gallinarum Δpmi mutant was only partially attenuated, and the ΔansB mutant was fully virulent. The Δfur Δpmi and Δfur ΔansB double mutants were attenuated but not protective when delivered orally to the chicks. However, a Δpmi Δfur strain was highly immunogenic when administered intramuscularly. All together, our results show that the fur gene is essential for the virulence of S. Gallinarum, and the fur mutant is effective as a live recombinant vaccine against fowl typhoid.


Subject(s)
Poultry Diseases/prevention & control , Salmonella Infections, Animal/prevention & control , Salmonella Vaccines/immunology , Salmonella enterica/immunology , Administration, Oral , Animals , Bacterial Proteins/genetics , Chickens , Gene Deletion , Injections, Intramuscular , Poultry Diseases/immunology , Repressor Proteins/genetics , Salmonella Infections, Animal/immunology , Salmonella Vaccines/administration & dosage , Salmonella Vaccines/isolation & purification , Salmonella enterica/genetics , Survival Analysis , Treatment Outcome , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/immunology , Vaccines, Attenuated/isolation & purification , Virulence
13.
Vet Microbiol ; 166(3-4): 567-75, 2013 Oct 25.
Article in English | MEDLINE | ID: mdl-23958403

ABSTRACT

Avian pathogenic Escherichia coli (APEC) cause avian colibacillosis, a poultry disease characterized by multiple organ infections resulting in significant economic loss in the poultry industry. Several virulence factors are important for disease manifestation in APEC of which, role of quorum sensing has not been investigated. Quorum sensing is a population dependent cell-cell signaling system which modulates numerous physiological processes such as biofilm formation and virulence in multiple species. LuxS, a well-known controller in the QS, plays a role in regulating virulence in various bacterial species. Here we investigated the role of LuxS in regulating virulence in APEC O78:K80:H9. Mutation of luxS resulted in a significant reduction of virulence in APEC O78:K80:H9, evidenced by both in vivo and in vitro assays such as decreased invasion of internal organs in chicken embryo, reduced lethality in chicken embryo lethality assay, and altered lipopolysaccharide (LPS) profile. In addition, the abilities of the knockout strain to survive in chicken macrophage cell lines and to invade in chicken embryo fibroblast cells were significantly diminished. Further, structure and expression level of the LPS profile was significantly altered in the knockout strain, which may be one of the contributing factors for the persistence and virulence of APEC. Complementation of luxS gene in trans restored the virulence of the knockout strain to the level of wild-type bacteria. Taken together, these results show that LuxS contributes to the virulence in APEC O78:K80:H9 strain and partly explain the role played by LuxS in the pathogenesis of APEC strains.


Subject(s)
Bacterial Proteins/metabolism , Carbon-Sulfur Lyases/metabolism , Escherichia coli Infections/veterinary , Escherichia coli/metabolism , Escherichia coli/pathogenicity , Poultry Diseases/microbiology , Animals , Bacterial Proteins/genetics , Carbon-Sulfur Lyases/genetics , Chickens , Escherichia coli/genetics , Escherichia coli Infections/microbiology , Quorum Sensing , Virulence , Virulence Factors/genetics , Virulence Factors/metabolism
14.
PLoS One ; 8(2): e55492, 2013.
Article in English | MEDLINE | ID: mdl-23383333

ABSTRACT

Urinary tract infections primarily caused by uropathogenic strains of Escherichia coli (E. coli) remain a significant public health problem in both developed and developing countries. An important virulence determinant in uropathogenesis is biofilm formation which requires expression of fimbriae, flagella, and other surface components such as lipopolysaccharides. In this study, we explored the regulation of uvrY and csrA genes in biofilm formation, motility and virulence determinants in uropathogenic E. coli. We found that mutation in uvrY suppressed biofilm formation on abiotic surfaces such as polyvinyl chloride, polystyrene and glass, and complementation of uvrY in the mutant restored the biofilm phenotype. We further evaluated the role of uvrY gene in expression of type 1 fimbriae, an important adhesin that facilitates adhesion to various abiotic surfaces. We found that phase variation of type 1 fimbriae between fimbriated and afimbriated mode was modulated by uvrY at its transcriptional level. Deletion mutant of uvrY lowered expression of fimbrial recombinase genes, such as fimB, fimE, and fimA, a gene encoding major fimbrial subunit. Furthermore, transcription of virulence specific genes such as papA, hlyB and galU was also reduced in the deletion mutant. Swarming motility and expression of flhD and flhC was also diminished in the mutant. Taken together, our findings unravel a possible mechanism in which uvrY facilitates biofilm formation, persistence and virulence of uropathogenic E. coli.


Subject(s)
Biofilms/growth & development , Escherichia coli Proteins/metabolism , Escherichia coli/physiology , Gene Expression Regulation, Bacterial/genetics , Genetic Pleiotropy/physiology , Transcription Factors/metabolism , Urinary Tract Infections/microbiology , Escherichia coli/pathogenicity , Escherichia coli Proteins/genetics , Fimbriae, Bacterial/metabolism , Genetic Complementation Test , Genetic Pleiotropy/genetics , Gentian Violet , Glass , Humans , Movement , Mutation/genetics , Oligonucleotides/genetics , Polystyrenes , Polyvinyl Chloride , RNA-Binding Proteins/metabolism , Real-Time Polymerase Chain Reaction , Repressor Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/genetics , Virulence
15.
Vaccine ; 31(7): 1094-9, 2013 Feb 04.
Article in English | MEDLINE | ID: mdl-23261043

ABSTRACT

Salmonella enterica serovar Gallinarum is the causative agent of fowl typhoid, an important systemic disease of poultry with economic consequences in developing nations. A live attenuated orally applied S. Gallinarum vaccine could provide a low cost method for controlling this disease. We constructed S. Gallinarum strains in which the expression of the crp, rfc and rfaH genes, important for virulence of Salmonella Typhimurium in mice, were under the control of an arabinose-regulated promoter. We evaluated the virulence of these strains compared to wild-type S. Gallinarum and to mutants carrying deletions in these genes. We found that rfc mutants were fully virulent, indicating that, unlike the S. Typhimurium mouse model, the rfc gene is dispensable in S. Gallinarum for virulence in birds. In the case of rfaH, the deletion mutant was attenuated and protective, while the strain with arabinose-regulated rfaH expression retained full virulence. The strain exhibiting arabinose-regulated crp expression was attenuated. Its virulence was not affected by the inclusion of 0.2% arabinose in the drinking water. Birds immunized with this strain were protected against a lethal S. Gallinarum challenge and against colonization with the human pathogen Salmonella Enteritidis. This work shows that an arabinose-regulated crp strain provides a basis for further development of a fowl typhoid vaccine.


Subject(s)
Poultry Diseases/microbiology , Poultry Diseases/prevention & control , Salmonella Infections, Animal/microbiology , Salmonella Infections, Animal/prevention & control , Salmonella Vaccines/adverse effects , Salmonella Vaccines/immunology , Salmonella/immunology , Animals , Chickens , Gene Deletion , Gene Expression Regulation, Bacterial , Poultry Diseases/immunology , Salmonella/pathogenicity , Salmonella Infections, Animal/immunology , Salmonella Vaccines/administration & dosage , Survival Analysis , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/adverse effects , Vaccines, Attenuated/immunology , Virulence , Virulence Factors/biosynthesis , Virulence Factors/genetics
16.
PLoS One ; 7(7): e40645, 2012.
Article in English | MEDLINE | ID: mdl-22792393

ABSTRACT

Salmonella enterica serovar Typhimurium, a gram-negative facultative rod-shaped bacterium causing salmonellosis and foodborne disease, is one of the most common isolated Salmonella serovars in both developed and developing nations. Several S. Typhimurium genomes have been completed and many more genome-sequencing projects are underway. Comparative genome analysis of the multiple strains leads to a better understanding of the evolution of S. Typhimurium and its pathogenesis. S. Typhimurium strain UK-1 (belongs to phage type 1) is highly virulent when orally administered to mice and chickens and efficiently colonizes lymphoid tissues of these species. These characteristics make this strain a good choice for use in vaccine development. In fact, UK-1 has been used as the parent strain for a number of nonrecombinant and recombinant vaccine strains, including several commercial vaccines for poultry. In this study, we conducted a thorough comparative genome analysis of the UK-1 strain with other S. Typhimurium strains and examined the phenotypic impact of several genomic differences. Whole genomic comparison highlights an extremely close relationship between the UK-1 strain and other S. Typhimurium strains; however, many interesting genetic and genomic variations specific to UK-1 were explored. In particular, the deletion of a UK-1-specific gene that is highly similar to the gene encoding the T3SS effector protein NleC exhibited a significant decrease in oral virulence in BALB/c mice. The complete genetic complements in UK-1, especially those elements that contribute to virulence or aid in determining the diversity within bacterial species, provide key information in evaluating the functional characterization of important genetic determinants and for development of vaccines.


Subject(s)
Comparative Genomic Hybridization , Genome, Bacterial , Salmonella typhimurium/genetics , Salmonella typhimurium/pathogenicity , Animals , Bacteriophages/genetics , Chickens/microbiology , Chromosomes, Bacterial , Gene Order , Genes, Bacterial , Mice , Phylogeny , Plasmids , Polymorphism, Single Nucleotide , Pseudogenes , Salmonella typhimurium/classification , Virulence
17.
PLoS One ; 7(2): e31348, 2012.
Article in English | MEDLINE | ID: mdl-22363626

ABSTRACT

Uropathogenic Escherichia coli (UPEC), a member of extraintestinal pathogenic E. coli, cause ∼80% of community-acquired urinary tract infections (UTI) in humans. UPEC initiates its colonization in epithelial cells lining the urinary tract with a complicated life cycle, replicating and persisting in intracellular and extracellular niches. Consequently, UPEC causes cystitis and more severe form of pyelonephritis. To further understand the virulence characteristics of UPEC, we investigated the roles of BarA-UvrY two-component system (TCS) in regulating UPEC virulence. Our results showed that mutation of BarA-UvrY TCS significantly decreased the virulence of UPEC CFT073, as assessed by mouse urinary tract infection, chicken embryo killing assay, and cytotoxicity assay on human kidney and uroepithelial cell lines. Furthermore, mutation of either barA or uvrY gene reduced the production of hemolysin, lipopolysaccharide (LPS), proinflammatory cytokines (TNF-α and IL-6) and chemokine (IL-8). The virulence phenotype was restored similar to that of wild-type by complementation of either barA or uvrY gene in trans. In addition, we discussed a possible link between the BarA-UvrY TCS and CsrA in positively and negatively controlling virulence in UPEC. Overall, this study provides the evidences for BarA-UvrY TCS regulates the virulence of UPEC CFT073 and may point to mechanisms by which virulence regulations are observed in different ways may control the long-term survival of UPEC in the urinary tract.


Subject(s)
Escherichia coli Proteins/metabolism , Membrane Proteins/metabolism , Phosphotransferases/metabolism , Signal Transduction , Transcription Factors/metabolism , Uropathogenic Escherichia coli/pathogenicity , Animals , Biological Assay , Cell Death/drug effects , Cell Line , Cell Movement/drug effects , Chick Embryo , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Down-Regulation/drug effects , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Epithelial Cells/pathology , Escherichia coli Proteins/genetics , Gene Deletion , Hemolysin Proteins/metabolism , Hemolysis/drug effects , Humans , Lipopolysaccharides/pharmacology , Membrane Proteins/genetics , Mice , Mutation/genetics , Phosphotransferases/genetics , Sheep , Signal Transduction/drug effects , Transcription Factors/genetics , Urinary Tract Infections/microbiology , Urinary Tract Infections/pathology , Uropathogenic Escherichia coli/drug effects , Uropathogenic Escherichia coli/genetics , Virulence/drug effects
18.
Fish Shellfish Immunol ; 31(6): 1142-53, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22015784

ABSTRACT

Edwardsiella ictaluri is an Enterobacteriaceae that causes lethal enteric septicemia in catfish. Being a mucosal facultative intracellular pathogen, this bacterium is an excellent candidate to develop immersion-oral live attenuated vaccines for the catfish aquaculture industry. Deletion of the cyclic 3',5'-adenosine monophosphate (cAMP) receptor protein (crp) gene in several Enterobacteriaceae has been utilized in live attenuated vaccines for mammals and birds. Here we characterize the crp gene and report the effect of a crp deletion in E. ictaluri. The E. ictaluri crp gene and encoded protein are similar to other Enterobacteriaceae family members, complementing Salmonella enterica Δcrp mutants in a cAMP-dependent fashion. The E. ictaluri Δcrp-10 in-frame deletion mutant demonstrated growth defects, loss of maltose utilization, and lack of flagella synthesis. We found that the E. ictaluri Δcrp-10 mutant was attenuated, colonized lymphoid tissues, and conferred immune protection against E. ictaluri infection to zebrafish (Danio rerio) and catfish (Ictalurus punctatus). Evaluation of the IgM titers indicated that bath immunization with the E. ictaluri Δcrp-10 mutant triggered systemic and skin immune responses in catfish. We propose that deletion of the crp gene in E. ictaluri is an effective strategy to develop immersion live attenuated antibiotic-sensitive vaccines for the catfish aquaculture industry.


Subject(s)
Aquaculture/methods , Bacterial Vaccines/immunology , Catfishes , Edwardsiella ictaluri/genetics , Enterobacteriaceae Infections/veterinary , Fish Diseases/microbiology , Fish Diseases/prevention & control , Receptors, Cyclic AMP/genetics , Administration, Oral , Amino Acid Sequence , Animals , Bacterial Vaccines/administration & dosage , Blotting, Western , Computational Biology , DNA Primers/genetics , Edwardsiella ictaluri/pathogenicity , Electrophoresis, Polyacrylamide Gel , Enterobacteriaceae Infections/prevention & control , Gene Deletion , Molecular Sequence Data , Mutation/genetics , Phenotype , Sequence Alignment , Vaccines, Attenuated/immunology , Virulence , Zebrafish
19.
Infect Immun ; 74(8): 4900-9, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16861679

ABSTRACT

The BarA-UvrY two-component system (TCS) in Escherichia coli is known to regulate a number of phenotypic traits. Both in vitro and in vivo assays, including the chicken embryo lethality assay, showed that this TCS regulates virulence in avian pathogenic E. coli (APEC) serotype O78:K80:H9. A number of virulence determinants, such as the abilities to adhere, invade, persist within tissues, survive within macrophages, and resist bactericidal effects of serum complement, were compromised in mutants lacking either the barA or uvrY gene. The reduced virulence was attributed to down regulation of type 1 and Pap fimbriae, reduced exopolysaccharide production, and increased susceptibility to oxidative stress. Our results indicate that BarA-UvrY regulates virulence properties in APEC and that the chicken embryo lethality assay can be used as a surrogate model to determine virulence determinants and their regulation in APEC strains.


Subject(s)
Chick Embryo/microbiology , Escherichia coli Proteins/metabolism , Escherichia coli/pathogenicity , Gene Expression Regulation, Bacterial , Membrane Proteins/metabolism , Phosphotransferases/metabolism , Poultry Diseases/microbiology , Transcription Factors/metabolism , Animals , Cells, Cultured , Escherichia coli/classification , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Infections/microbiology , Escherichia coli Infections/mortality , Escherichia coli Infections/veterinary , Escherichia coli Proteins/genetics , Fibroblasts/microbiology , Membrane Proteins/genetics , Phosphotransferases/genetics , Poultry Diseases/mortality , Signal Transduction , Transcription Factors/genetics , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL